We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-11.04%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$175M
AUM Growth
-$20.2M
Cap. Flow
+$10.1M
Cap. Flow %
5.76%
Top 10 Hldgs %
36.8%
Holding
85
New
16
Increased
25
Reduced
11
Closed
19

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$3.77M
2
VAR
Varian Medical Systems, Inc.
VAR
+$3.33M
3
BSX icon
Boston Scientific
BSX
+$3.08M
4
ELGX
Endologix Inc
ELGX
+$2.78M
5
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$2.76M

Top Sells

Rank Stock Value
1
SIEN
Sientra, Inc.
SIEN
+$5.61M
2
ALIM
Alimera Sciences
ALIM
+$4.5M
3
SPNC
Spectranetics Corp
SPNC
+$4.48M
4
COO icon
Cooper Companies
COO
+$4.42M
5
CPHD
Cepheid Inc
CPHD
+$3.33M

Sector Composition

Rank Sector Weight
1 Healthcare 65.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXTM
76
CALL
DELISTED
NxStage Medical Inc.
NXTM
– –
-100,000
Closed -$1.43M
IPXL
77
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-21,543
Closed -$1.04M
SPNC
78
DELISTED
Spectranetics Corp
SPNC
– –
-250,000
Closed -$4.48M
CPHD
79
DELISTED
Cepheid Inc
CPHD
– –
-60,000
Closed -$3.33M
FEIC
80
CALL
DELISTED
FEI COMPANY
FEIC
– –
-30,000
Closed -$2.58M
THOR
81
PUT
DELISTED
THORATEC CORPORATION
THOR
– –
-50,000
Closed -$2.23M
RCPT
82
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-11,000
Closed -$2.51M
NDRM
83
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
– –
-53,000
Closed -$1.01M
AGN
84
DELISTED
Allergan Inc
AGN
– –
-7,000
Closed -$2.32M
1 2 3
4

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2015 Portfolio in Review

As of Q3 2015, Pura Vida Investments held 85 positions worth $175M, down 10% from $195M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $10.1M of net new capital in Q3 2015, opening 16 new positions and adding to 25 existing holdings. Its largest new stake was Abbott: 80,000 shares worth $3.22M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 70% a quarter earlier.

On the sell side, the largest reduction was Alimera Sciences, an estimated $4.5M trimmed.

  • Pura Vida Investments's largest Q3 2015 buy was Abbott: 80,000 shares worth $3.22M.
  • Pura Vida Investments added most to Boston Scientific in Q3 2015, an estimated $3.08M increase.
  • Pura Vida Investments's biggest Q3 2015 reduction was Alimera Sciences, cutting an estimated $4.5M.
  • Pura Vida Investments fully exited Sientra, Inc. in Q3 2015, selling an estimated $5.61M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $175M portfolio in Q3 2015.
  • Pura Vida Investments opened 16 new positions and closed 19 in Q3 2015.
  • Pura Vida Investments's portfolio value fell 10% quarter-over-quarter to $175M.

Based on Pura Vida Investments's 13F filing for Q3 2015, filed 16 Nov 2015.